# A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer

> **NCT00144066** · PHASE3 · COMPLETED · sponsor: **West Japan Thoracic Oncology Group** · enrollment: 600 (—)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** platinum-based chemotherapy alone (up to six cycles)
- **DRUG:** platinum-based chemotherapy followed by maintenance therapy with gefitinib

## Key facts

- **NCT ID:** NCT00144066
- **Lead sponsor:** West Japan Thoracic Oncology Group
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 600 (—)
- **Last updated:** 2005-09-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00144066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00144066, "A Randomized Phase III Trial of Chemotherapy Alone Versus Chemotherapy Followed by Gefitinib in Stage IIIB/IV Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00144066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*